Histone Posttranslational Modifications and Chromatin Remodelers in Prostate Cancer
Authors:
- Filipa Quintela VieiraFVFilipa Quintela Vieira
- Diogo Almeida-RiosDADiogo Almeida-Rios
- Inês GraçaIGInês Graça
- Rui HenriqueRui Henrique
- Carmen JerónimoCarmen Jerónimo
- 1 January 2016
- book chapter
- Published by Elsevier
- p. 447-465
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cellsCancer Letters, 2011
- Epigenetic regulation of prostate cancerClinical Epigenetics, 2011
- Histone arginine methylationFEBS Letters, 2010
- Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell linesThe Prostate, 2010
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)Cancer, 2009
- Chemical mechanisms of histone lysine and arginine modificationsBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2009
- Chromatin Modifications and Their FunctionCell, 2007
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcriptionNature, 2005
- Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1Cell, 2004
- Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate CancerThe Prostate, 2004